BSEAGM/EGM2d ago · 22 Jul 2026, 11:53 pm

Anthem Biosciences Limited has informed the Exchange regarding the Proceedings of the 20th Annual General Meeting held on Wednesday, July 22, 2026

Anthem Biosciences Ltd · 544449

✦ AI SummaryResults

Anthem Biosciences Limited held its 20th Annual General Meeting (AGM) on July 22, 2026, through video conferencing. The meeting was conducted in compliance with applicable laws and regulations. The AGM transacted various businesses, including the adoption of audited financial statements, declaration of dividend, appointment of statutory auditors, and approval of related party transactions. The meeting was attended by the company's directors, statutory auditors, and internal auditors, and was conducted through remote e-voting.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Anthem Biosciences Ltd - 544449 - Announcement Under

Attachments (1)

📄

6653d5bd-31ce-4a5d-94bd-29a8b7755a03.pdf

pdf

Download →
View document text
Date: July 22, 2026 BSE Limited, National Stock Exchange of India Limited 20th Floor, P.J. Towers, Exchange Plaza, C-1, Block G, Dalal Street, Bandra Kurla Complex, Bandra (E), Mumbai - 400001. Mumbai – 400 051 BSE Scrip Code: 544449 NSE Scrip Symbol: ANTHEM Subject: Proceedings of the 20th Annual General Meeting of the Company Dear Sir/Ma’am Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), please find enclosed the proceedings of the 20th Annual General Meeting ("AGM") of the Company held on Wednesday, July 22, 2026, through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM"), at which the business set out in the Notice convening said AGM was duly transacted. The above intimation is made available in the website of the Company at https://anthembio.com/. We request you to kindly take the same on record. Thanking you, Yours truly, For Anthem Biosciences Limited Divya Prasad Company Secretary & Compliance Officer Membership No: A41438 Proceedings of the 20th Annual General Meeting of Anthem Biosciences Limited The 20th Annual General Meeting ("AGM"/"Meeting") of the Members of Anthem Biosciences Limited ("Company") was held on Wednesday, July 22, 2026 at 3:30 p.m. (IST) through Video Conferencing ("VC") / Other Audio-Visual Means ("OAVM") and concluded at 4.40 p.m. (IST) to transact the businesses set out in the Notice convening the AGM. Ms. Divya Prasad, Company Secretary and Compliance Officer of the Company, welcomed the Members to the AGM and briefed them on the manner of participation in the Meeting through VC/OAVM. She informed the Members that the Meeting was being convened in compliance with the applicable provisions of the Companies Act, 2013, the Rules made thereunder, the circulars issued by the Ministry of Corporate Affairs, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Secretarial Standard-2 on General Meetings. She also explained the e-voting process and other procedural matters relating to the conduct of the Meeting. Mr. Ajay Bhardwaj, Chairperson, Managing Director and Chief Executive Officer of the Company, Chaired the Meeting. Upon confirmation of the requisite quorum being present, the Chairperson called the Meeting to order. All the Directors of the Company, the Chief Financial Officer, representatives of M/s. K.P. Rao & Co., Chartered Accountants, Statutory Auditors, representatives of M/s. BMP & Co. LLP, Secretarial Auditors, the Scrutinizer and members, M/s BPU & Co., Charted Accountants, Internal Auditors and the senior management team attended the Meeting through VC/OAVM from their respective locations. Since the AGM was conducted through VC/OAVM, in accordance with the applicable MCA and SEBI Circulars, the facility for appointment of proxies was not available. However, authorised representatives of corporate members attended the Meeting in accordance with the provisions of the Companies Act, 2013. The statutory registers and other documents referred to in the Notice convening the AGM were made available electronically for inspection by the Members. With the consent of the Members present, the Notice convening the AGM was taken as read. The Members were informed that the Reports of the Statutory Auditors for the financial year ended March 31, 2026 did not contain any qualification, reservation or adverse remark and were accordingly taken as read. The Chairperson then addressed the Members and shared his reflections on the Company's performance during FY 2025-26, the successful listing of the Company, key strategic initiatives, business outlook and long-term growth plans. Thereafter, Mr. Mohammed Gawir Baig, Chief Financial Officer, shared an overview with Shareholders the operational and financial performance of the Company for FY 2025- 26 and highlighted the Company's key financial and operational achievements. In terms of the Notice convening the 20th AGM, the following business was transacted through remote e-voting prior to the Meeting as well as through e-voting upon conclusion of Meeting: SI No Description of Resolution Ordinary Businesses 1. Approval for adoption of the audited financial statements (including audited consolidated financial statements) of the company for the financial year ended March 31, 2026 and the reports of the Board of Directors and Auditors thereon. (Ordinary Resolution) 2. Approval for Declaration of dividend. (Ordinary Resolution) 3. Approve the appointment of Mr. K Ravindra Chandrappa (DIN: 01580534), who retires by rotation and being eligible, offers himself for re-appointment (Ordinary Resolution) 4. Appointment of M/S. S.R. Batliboi & Associates LLP, chartered accountants, (FRN 101049W/ E300004) as the statutory auditors of the Company. (Ordinary Resolution) Special Businesses 5. Approval of the continuation of Mr. Ravikant Uppal (DIN: 00025970) as non-executive independent director upon attaining the age of 75 years. (Special Resolution) 6. Approval of commission payable to Independent Directors. (Ordinary Resolution) 7. Approval for increase in payment of remuneration to related parties holding an office or place of profit. (Ordinary Resolution) 8. Approval of the Upside Sharing Arrangement with Viridity Tone LLP. (Ordinary Resolution) Members who had registered themselves as speakers were provided an opportunity to express their views and seek clarifications Company's performance and the agenda items placed before the Meeting. The Chairperson and the Management appropriately responded to the queries raised by the Members. Members were also informed that any further queries could be addressed to the Company through the designated investor relations email address investors.abl@anthembio.com The e-voting facility remained open for 15 minutes after the conclusion of the Meeting to enable the Members who had not cast their votes earlier to exercise their voting rights. Mr. Pramod S M, Designated Partner of M/s. BMP & Co. LLP, Practicing Company Secretaries, acted as the Scrutinizer for the voting process. The Members were informed that the voting results, along with the Scrutinizer's Report, would be declared within the prescribed timeline and uploaded on the websites of the Company and the Registrar and Transfer Agent and would also be submitted to the Stock Exchanges. Thereafter, the Chairperson thanked the Members for their participation and declared the Meeting concluded. All the resolutions set out in the Notice convening the AGM were passed by the Members with the requisite majority. This is for your information and records. Thanking you, Yours truly, For Anthem Biosciences Limited Divya Prasad Company Secretary & Compliance Officer Membership No: A41438